• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Unique randomized trial tests VEGF inhibitor in patients with recurrent glioblastoma

    Glioblastoma, the most common and lethal type of malignant brain tumor, has a poor prognosis and very few chemotherapeutic options

    Health Communication Core

    The Health Communication Core provides communication support to members in areas such as cancer prevention education and communication, recruitment to clinical research studies, and public outreach

    Elias Zerhouni, MD, Director of NIH, to step down in late October
    Twelve New Members Join DF/HCC

    Twelve individuals have recently joined DF/HCC

    DF/HCC Nodal Awards announced

    DF/HCC offers a multitude of funding opportunities to its members to encourage and enhance the collaborative spirit of research within the Harvard medical community

    Success of two DF/HCC SPOREs prompts renewals

    The DF/HCC Lung SPORE, led by Bruce Johnson, MD (DFCI) (left), and the Multiple Myeloma SPORE, led by Kenneth Anderson, MD (DFCI) (right), have each been highly successful in creating cohesion in their respective research programs, sparking new RO1, PO1, and DOD grants, fostering innovative ideas in cancer research, and advancing the careers of junior investigators

    DNA Resource Core

    The DNA Resource Core provides DNA sequencing services and sequence verified plasmid constructs

Displaying results 127 to 133 out of 206